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Abstract
Background. The following position statement from the Union of the European
Phoniatricians, updated on 25th May 2020 (superseding the previous statement issued on
21st April 2020), contains a series of recommendations for phoniatricians and ENT surgeons
who provide and/or run voice, swallowing, speech and language, or paediatric audiology
services.
Objectives. This material specifically aims to inform clinical practices in countries where
clinics and operating theatres are reopening for elective work. It endeavours to present a
current European view in relation to common procedures, many of which fall under the
aegis of aerosol generating procedures.
Conclusion. As evidence continues to build, some of the recommended practices will
undoubtedly evolve, but it is hoped that the updated position statement will offer clinicians
precepts on safe clinical practice.
Introduction
The coronavirus disease 2019 (Covid-19) pandemic continues. However, new-onset infec-
tion and mortality rates appear to have come to a plateau or to have decreased in many
countries. The following material is presented to inform the practices of ENT surgeons
and phoniatricians in particular, in countries where clinics and operating theatres are
reopening for elective work.
The following position statement from the Union of the European Phoniatricians,
updated on 25th May 2020 (superseding the previous statement issued on 21st April
2020), contains a series of recommendations for phoniatricians and ENT surgeons who
provide and/or run voice, swallowing, speech and language, or paediatric audiology
services.
The opinions and recommendations below are the collective recommendations of the
Union of the European Phoniatricians presented through the authors in their personal
capacities. They are not necessarily the same in each of the authors’ own hospital or clinic,
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neither do they necessarily represent the opinion of the
authors’ hospital or practice. In addition, this position state-
ment does not act as a policy that is enforceable, but rather
as a collection of recommendations.
Healthcare providers are at high risk of contracting the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus.
Of the first 138 SARS-CoV-2 in-patients, 40 were healthcare
workers.1 Among healthcare practitioners, ENT surgeons and
phoniatricians are at increased risk.2 As a poignant example,
the first documented death of a physician was that of an ENT
surgeon in Wuhan, China, on 25th January 2020.3
This increased risk is due in part to exposure to aerosol
generation,4 a result of the presence of the virus in the nasal
and pharyngeal cavities of infected individuals. Viral load
has been noted to be higher in the nose than the throat.
This places practitioners who carry out nasendoscopic exami-
nations at higher risk, including phoniatricians and ENT sur-
geons, particularly laryngologists.5
The risk of infection likely results not only from an infec-
tious aerosol being directly inhaled, but also from it forming
on contaminated surfaces, both during and after procedures.
An increased risk of exposure has been found during head
and neck examinations and endoscopies, and during inter-
ventions performed in the upper airway and food pas-
sages.5–8
Some asymptomatic individuals have been found to har-
bour active viral infection and to be potentially infectious.
Viral load in infected but asymptomatic individuals has been
noted to be similar to that in symptomatic patients.5 This is
underscored by a study from a large German outbreak that
showed 22.2 per cent of all infected individuals to be asymp-
tomatic. Even in areas where there had been extensive testing,
there may be five times as many unrecognised cases.9
Accordingly, personal protective equipment (PPE), includ-
ing respiratory filtering facepiece code 3 (FFP3) masks, face
and eye protection, caps, gloves and fluid-resistant gowns,
should be used, even if the patient is totally asymptomatic,
whenever the procedure includes examination or manipulation
of the patient’s throat, nose, larynx or upper airway. Video
examples of donning PPE can be found online.10,11 The use
of such equipment is important wherever such examinations
take place, be it in community polyclinics, private clinics, hos-
pital out-patient settings or wards, emergency departments,
intensive care settings, or operating theatres.
As mentioned above, phoniatric and ENT clinics are now
being reopened in many countries, with the proviso being
that patient-related pathways and clinic or hospital-related
guidelines must be followed. This applies generally, but is par-
ticularly essential in clinical scenarios that include potential
aerosol generating procedures.
An aerosol generating procedure is a procedure that poten-
tially stimulates the explosive expulsion of air via coughing,
sneezing and so on that results in the release of airborne par-
ticles, thereby increasing the risk of airborne transmissions of
infections that are classically spread by droplet transmission.
Such procedures include, for example, but are not limited to:
(1) tracheostomy operations, including percutaneous dilatation
tracheostomy; (2) intubation and extubation; (3) open suction-
ing, positive airway pressure, jet ventilation, high-frequency
ventilation and high-flow nasal oxygen; (4) bronchoscopy;
(5) flexible or rigid endoscopic oral, transnasal, and laryngeal
examinations, including office operations; (6) drainage of
quinsy infections; (7) management of epistaxis; (8) removal
of fish bones or other foreign bodies in the pharynx or nasal
cavity; (9) transoral or transnasal injections into the larynx;
(10) transoral or transnasal oesophagoscopy or gastroscopy;
(11) face-to-face transcricothyroid or transoral injection into
the larynx, pharynx or mouth; (12) face-to-face ultrasound-
guided injections or procedures in the head and neck; and
(13) face-to-face dental or oral cavity procedures.
The precautions and suggestions are discussed below under
different clinical scenarios. ‘Telehealth’ in the text refers to
instances in which both the care provider and the patient
are communicating remotely through video and/or audio
applications.
Based on the fact that the current situation may continue
for months, if not longer, we recommend the following prac-
tices (as the new ‘norm’).
General recommendations
Routine face-to-face examinations, office procedures and
operations of an elective nature should only be undertaken
on asymptomatic patients. Asymptomatic patients undergoing
elective office procedures or operations under local or general
anaesthesia that include mucosal surface puncture or injec-
tions should be SARS-CoV-2 tested 2–3 days before the
operation, followed by quarantine until the operation day.
Symptomatic patients should be regarded as Covid-19 positive
until proven otherwise.
Video-endoscopy is preferred to ‘naked eye’ nasendoscopy.
Topical anaesthesia of the nasal cavity is preferably carried out
with anaesthetic-soaked cotton or gel rather than spray, or is
avoided completely. After each procedure with patients gagging
or coughing, there should be a minimal time interval of 30 min-
utes to allow for thorough cleaning of the facility. Such an inter-
val may alter depending on the facilities in which the procedure
takes place, most importantly the frequency of room air changes.
This applies to nasendoscopy and video-laryngoscopy, office
procedures, and fibre-optic endoscopic evaluations of swallow-
ing. A paradigm shift is required, away from face-to-face exam-
ination and towards the provision of diagnostics and therapy
through solutions embracing telehealth.
Voice or airway practice
Office examination
Routine office examinations can be recommenced for elective
ENT procedures, and phoniatric patients and services, provid-
ing that the local Covid-19 pandemic-related situation has sta-
bilised and guidelines are followed. Priority should be given to
patients in whom there is the possibility of malignancy or air-
way compromise. Full PPE, including FFP3 masks, should be
used, even during the examination of asymptomatic patients.
This includes tracheostomy tube changes, and changes to or
adjustments of voice prostheses.
Office procedures
Office procedures under local (or no) anaesthesia that include
puncture of the vocal folds or mucosal cover can be under-
taken; however, full PPE including FFP3 masks must be
worn, and the patient should be SARS-CoV-2 tested 2–3
days prior to the operation. Such operations include, for
example, vocal fold augmentation and other procedures con-
ducted through a channelled fibrescope. Ideally, such
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operations should be performed in ventilated, low-pressurised
rooms.
Laryngeal procedures under general anaesthesia
Laryngeal procedures in the operating theatre can be under-
taken for asymptomatic patients, but they should be preceded
by SARS-CoV-2 testing 2–3 days prior to the operation.
Priority must be given to cases where a malignancy is sus-
pected and the need for biopsies or curative surgery is
imperative, or where the airway itself is at risk.
Countrywide or local guidelines should be followed as to
the prioritising of patients.
Operations such as tracheostomy, and those involving jet
ventilation, high-flow humidified oxygen, laser, microdebri-
der and suction cautery, pose a greater risk to the surgeon
and operating theatre personnel. Flow-controlled ventilation
utilising small-bore, cuffed intubation tubes may offer a
safer alternative to jet ventilation in certain circumstances.
In general, these operations should be preceded by adaptation
of the operating theatre to lower pressure. Over-pressure
could increase the risk of viral spreading (in the instance of
a patient with a false negative test result). Surgical suction
devices and smoke evacuators should be equipped with filtra-
tion systems with greater than 99 per cent efficiency at
removing particles sized 0.1 nm, thereby diminishing the
risk of contamination during the operation. That said, filtra-
tion devices do not change the classification of an aerosol
generating procedure.
Patient testing
In an elective case scenario, and in the absence of symptoms
that can be attributed to SARS-CoV-2, one negative test should
be adequate. In an emergency scenario, testing or awaiting the
result of a test should not delay an operation; however,
SARS-CoV-2 positivity must be assumed.
In elective circumstances, patients with positive results, and
in the absence of SARS-CoV-2 symptoms, should be retested
to avoid delays due to false positive results. A confirmed posi-
tive result mandates the delay of surgery for at least two weeks
and until a further test is negative (assuming such a delay does
not entail danger to the patient’s airway or life).
All emergency cases in which SARS-CoV-2 testing is not
possible due to time constraints, or in which the test has
come back as positive, should be considered to be
SARS-CoV-2 positive. When operating on positive cases,
PPE ideally includes powered air-purifying respirators for all
personnel in the operating theatre.12
Telehealth
Positive lessons of telehealth learned during the pandemic
should continue to be utilised both in history taking and in pro-
visions of voice and other phoniatric therapy to our patients.
Face-to-face voice therapy should be changed to remote voice
therapy. Smartphone applications should be utilised if available.
Telehealth tools and real-time video communication must com-
ply with national safety and security regulations.
Botulinum injection patients
This section concerns patients receiving regular botulinum
injections for voice spasms, tremors or vocal fold dysfunction.
In asymptomatic patients, injections performed under electro-
myography (EMG) guidance that do not puncture the vocal
fold mucosal covering can be undertaken, without prior
SARS-CoV-2 testing, if all healthcare providers in the proced-
ure room wear PPE including FFP3 masks. Such injections
include, for example, those performed via a cricothyroid
approach into the thyroarytenoid muscle. Similar recommen-
dations apply to laryngeal EMG examinations. Patients should
also wear surgical masks during the procedure. History taking
and patient interview should be conducted utilising telehealth
or in a room separate from the one in which the actual proced-
ure is undertaken.
Injections carried out through a channelled fibrescope, and
other injections likely to induce cough, for example those into
the posterior cricoarytenoid muscle, or those through a trans-
tracheal, translaryngeal or transoral route, should only be per-
formed after a confirmed negative status on a SARS-CoV-2
test, but still under strict PPE adherence (because of the risk
of a false negative result).
Swallowing
Fibre-optic evaluations of swallowing and videofluoroscopic
swallow studies are aerosol generating procedures. Such exam-
inations require PPE including FFP3 masks.
In cases where there is a clear need for the assessment of
swallowing, to enable decisions such as those relating to percu-
taneous endoscopic gastrostomy placement, it is preferable to
use videofluoroscopy or modified fibre-optic endoscopic eva-
luations of swallowing with only one or two food and liquid
consistencies, in order to minimise the duration of the actual
procedure.
For new referrals, each department or team needs to deter-
mine the ‘time sensitivity’, ‘urgency’ and ‘preferred short
protocol’ on a case-by-case basis. They must take into account
each patient’s medical condition, social circumstances and
needs. Swallowing examination and therapy can potentially
be started through remote telehealth options.
On the ward, Covid-19 positive patients with swallowing
problems should be managed, if possible, through indirect
assessment and treatment provided by the healthcare person-
nel who are caring for them. Remote telehealth and diagnos-
tics should be used for such patients as much as possible.
In Covid-19 suspected patients, it is recommended that the
healthcare provider stands 2 m away from the patient while
evaluating oromotor function. Closer contact is required
when assessing oral mucosa, palate and dentition. If closer
contact is needed, the investigator should stand to the side
of the bed, facing away from the patient. The PPE must be
worn in accordance with local guidelines, but with a minimum
of an FFP3 mask, visor, cap and fluid-resistant gown.
Speech and language
Speech and language assessment should be undertaken par-
tially or wholly through telehealth, whenever possible.
Routine questionnaires that can be completed prior to the
actual consultation should be used and be available to the
examiner.
When treating children, the number of adults accompany-
ing the child on each visit should be limited to one. When
treating adults, they should be requested to visit the clinics
alone, unless their underlying cognitive, motor or other med-
ical conditions require carers to be present.
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Paediatric audiology
Children with acute conditions necessitating a visit to the
hearing centre will need to be seen on a face-to-face basis.
It is recommended that the ear examination and hearing
assessment be undertaken as expeditiously as possible.
Screening questionnaires should be completed by the parent
prior to the consultation, in an attempt to assist the examiner
and prioritise therapy.
Screening of newborn hearing should be maintained. This
includes the Early Detection of Hearing Impairment assess-
ment for neonates who are suspected (based on screening
assessments) to have congenital hearing impairment.
In general, the duration of face-to-face clinical interactions
between the clinician and child, and time spent waiting by the
child in the clinic, should be kept to the minimum, with no
waiting time at all if possible.
Disinfection
Extensive attention should be given to disinfection of the
examination rooms and the equipment within them. We rec-
ommend strict compliance with local health and safety regula-
tions relating to sterilisation and disinfection. The use of
disposable equipment is preferred wherever possible.
Reimbursement
The Union of the European Phoniatricians recommends that
telehealth and teleconsultations be recognised and reimbursed
in accordance with local and national policies during this
Covid-19 pandemic.
Confidentiality
Confidentiality is paramount. General data protection regula-
tions, local and regional variants, and appropriate legislation
must be complied with. In particular, when undertaking a
remote consultation, the examiner must: introduce themselves
thoroughly, explain the rationale for the examination and
obtain informed consent to proceed. They must document
the examination in some form of a contemporaneous manner,
and must send their findings (with permission of the patient
or carer) to the referring general practitioner or physician
and other appropriate individuals. The examiner must be
aware of their duty of care, be alert to safeguarding issues
and understand the mechanism of escalation.
• ENT and phoniatric practitioners undertake aerosol generating
procedures, and are at high risk of contracting coronavirus disease 2019
(Covid-19)
• Asymptomatic carriers of the virus are commonplace, and false negative
tests occur
• Thus, all surgical interventions must be viewed from the perspective of
management of a Covid-19 positive patient
• Symptomatic patients should be regarded as Covid-19 positive until
proven otherwise
• A paradigm shift is required, away from face-to-face examination, to
provision of diagnostics and therapy through solutions embracing
telehealth
• Asymptomatic patients should be tested 2–3 days before operations,
followed by quarantine until operation day
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